1999
DOI: 10.1038/sj.pcan.4500325
|View full text |Cite
|
Sign up to set email alerts
|

Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2001
2001
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…This region has been suggested as a tumor suppressor locus for liver cancer (Ricketts et al 2002) and is involved in translocation in lymphoma (Cuneo et al 2001). One end of this region coincides with an insertion of prostate surface antigen and prostate cancer prognostic marker gene FOLH1 (Maraj and Markham 1999) found in mouse chromosome 7qD3. This gene together with its flanking newly evolved human-specific genes, FGCP, is located at the breakpoint joining mouse 2qE1 and 2qD.…”
Section: Protection Of Tspri Dna Fragments From Exonuclease III Digesmentioning
confidence: 99%
“…This region has been suggested as a tumor suppressor locus for liver cancer (Ricketts et al 2002) and is involved in translocation in lymphoma (Cuneo et al 2001). One end of this region coincides with an insertion of prostate surface antigen and prostate cancer prognostic marker gene FOLH1 (Maraj and Markham 1999) found in mouse chromosome 7qD3. This gene together with its flanking newly evolved human-specific genes, FGCP, is located at the breakpoint joining mouse 2qE1 and 2qD.…”
Section: Protection Of Tspri Dna Fragments From Exonuclease III Digesmentioning
confidence: 99%
“…In the present study, we screened the normal and cancer tissue-specific proteins among 14 different tissues. Some well-known tissue-specific proteins were also identified, such as ESR1 in breast cancer, shown to be associated with high grade and high proliferation (Moelans et al, 2010), CDX2 in colorectal cancer, used as a highly sensitive and specific marker of adenocarcinomas of intestinal origin (Werling et al, 2003), KLK2 and KLK3 in prostate cancer, utilized as biomarkers (Penney et al, 2011), and ACPP and FOLH1, identified as prostate-specific cancer proteins (Maraj and Markham, 1999). Of the 14 tissues examined, thyroid cancer tissue has the highest number of cancer tissue-specific proteins (103), including the well-known thyroid specific proteins TG and TPO (González et al, 2002).…”
Section: Discussionmentioning
confidence: 99%